Guideline-directed medical therapy (GDMT) for heart failure (HF) reduces major adverse cardiovascular events (MACE), including cardiac death and HF hospitalization. However, whether comorbidities influence GDMT effectiveness and dose optimization remains unclear.
To determine whether the association betwee...
S. Higuchi, Y. Shiraishi, T. Kohno et al.· European Heart Journal· 0 citations
BACKGROUND
Guideline-directed medical therapy (GDMT) improves prognosis in heart failure (HF), but its implementation remains suboptimal, particularly in patients with multiple risk domains.
METHODS
We analyzed the association between GDMT achievement and the 2-year composite endpoint of cardiac death or HF hospitali...
S. Higuchi, Y. Shiraishi, Takashi Kohno et al.· American Journal of Medicine· 0 citations
BACKGROUND
To evaluate the prognostic value of urinary neutrophil gelatinase-associated lipocalin (NGAL) normalized to creatinine in patients with acute coronary syndrome (ACS), focusing on left ventricular ejection fraction (LVEF).
METHODS
This retrospective cohort study included 144 patients emergently admitted for...